One-Compartment Open Model: Intravenous Bolus Administration
One-Compartment Open Model: Intravenous Bolus Administration
Introduction
The most common and most desirable route of drug administration is orally—by
mouth—using tablets, capsules, or oral solutions. In developing pharmacokinetic
models to describe and predict drug disposition kinetically, the model must
account for both the route of administration and the kinetic behavior of the drug in
the body.
The one-compartment open model offers the simplest way to describe the process
of drug distribution and elimination in the body. This model assumes that the drug
can enter or leave the body (ie, the model is "open"), and the body acts like a
single, uniform compartment. The simplest route of drug administration from a
modeling perspective is a rapid intravenous injection (IV bolus). The simplest
kinetic model that describes drug disposition in the body is to consider that the
drug is injected all at once into a box, or compartment, and that the drug distributes
instantaneously and homogenously throughout the compartment. Drug elimination
also occurs from the compartment immediately after injection.
Of course, this model is a simplistic view of drug disposition in the body, which in
reality is infinitely more complex than a single compartment. In the body, when a
drug is given in the form of an IV bolus, the entire dose of drug enters the
bloodstream immediately, and the drug absorption process is considered to be
instantaneous. In most cases, the drug distributes via the circulatory system to
potentially all the tissues in the body.
Uptake of drugs by various tissue organs will occur at varying rates, depending on
the (blood flow to the tissue, the lipophilicity of the drug, the molecular weight of
the drug, and the binding affinity of the drug for the tissue mass).
Most drugs are eliminated from the body either through the kidney and/or by being
metabolized in the liver. Because of rapid drug equilibration between the blood and
tissue, drug elimination occurs as if the dose is all dissolved in a tank of uniform
fluid (a single compartment) from which the drug is eliminated. The volume in
which the drug is distributed is termed the apparent volume of distribution, V D.
The apparent volume of distribution assumes that the drug is uniformly distributed
in the body. The V D is determined from the preinjected amount of the dose in the
syringe and the plasma drug concentration resulting immediately after the dose is
injected.
The one-compartment open model does not predict actual drug levels in the tissues.
However, the model assumes that changes in the plasma levels of a drug will result
in proportional changes in tissue drug levels, since their kinetic profile is consistent
with inclusion within the vascular compartment and the various drug
concentrations within the compartment are in equilibrium. The drug in the body, D
B, cannot be measured directly; however, accessible body fluids (such as blood)
can be sampled to determine drug concentrations.
The rate of elimination for most drugs from a tissue or from the body is a first-
order process, in which the rate of elimination is dependent on the amount or
concentration of drug present. The elimination rate constant, k, is a first-order
elimination rate constant with units of time– 1 (eg, hr– 1 or 1/hr). Generally, the
parent or active drug is measured in the vascular compartment. Total removal or
elimination of the parent drug from this compartment is effected by metabolism
(biotransformation) and excretion. The elimination rate constant represents the sum
of each of these processes:
K = Km +Ke
where D B = drug in the body at time t and D B 0 = drug in the body at t = 0. When
log D B is plotted against t for this equation, a straight line is obtained. In practice,
instead of transforming values of D B to their corresponding logarithms, each value
of D B is placed at logarithmic intervals on semilog paper.
Each individual tissue in the body may contain a different concentration of drug
due to differences in drug affinity for that tissue. Therefore, the amount of drug in
a given location can be related to its concentration by a proportionality constant
that reflects the volume of fluid the drug is dissolved in. The volume of distribution
represents a volume that must be considered in estimating the amount of drug in
the body from the concentration of drug found in the sampling compartment. The
volume of distribution is also the apparent volume (V D) in which the drug is
dissolved. Because the value of the volume of distribution does not have a true
physiologic meaning in terms of an anatomic space, the term apparent volume of
distribution is used.
The amount of drug in the body is not determined directly. Instead, a blood sample
is removed at periodic intervals and analyzed for its concentration of drug. The V D
relates the concentration of drug in plasma (C p) and the amount of drug in the
body (D B), as in the following equation:
The apparent volume of distribution is not a true physiologic volume. Most drugs
have an apparent volume of distribution smaller than, or equal to, the body mass.
For some drugs, the volume of distribution may be several times the body mass
and for a given dose, a very small C p 0 may occur in the body due to concentration
of the drug in peripheral tissues and organs. For this dose, the small C p 0 will result
in a large V D.
Drugs with a large apparent V D are more concentrated in extravascular tissues and
less concentrated intravascularly. If a drug is highly bound to plasma proteins or
remains in the vascular region, then C p 0 will be higher, resulting in a smaller
apparent V D. Consequently, binding of a drug to peripheral tissues or to plasma
proteins will significantly affect V D.
Clearance is a measure of drug elimination from the body without identifying the
mechanism or process. Drug elimination from the body is an ongoing process due
to both metabolism (biotransformation) and drug excretion through the kidney and
other routes. The mechanisms of drug elimination are complex, but collectively
drug elimination from the body may be quantitated using the concept of drug
clearance.
Drug clearance refers to the volume of plasma fluid that is cleared of drug per unit
time. Clearance may also be considered as the fraction of drug removed per unit
time multiplied by the V D. The rate of drug elimination may be expressed in
several ways, each of which essentially describes the same process, but with
different levels of insight and application in pharmacokinetics.
The expression of drug elimination from the body in terms of mass per unit time
(eg, mg/min, or mg/hr) is simple and absolute. For a zero-order elimination
process, expressing the rate of drug elimination as mass per unit time is convenient
because the rate is constant. In contrast, the rate of drug elimination for a first-
order elimination process is not constant and changes with respect to the drug
concentration in the body. For a first-order elimination, drug clearance expressed
as volume per unit time (eg, L/hr or mL/min) is convenient because it is a constant.
The concept of expressing a rate in terms of volume per unit time is common in
pharmacy. For example, a patient may be dosed at the rate of 2 teaspoonsful (10
mL) of a liquid medicine (10 mg/mL) daily, or alternatively, a dose (weight) of
100 mg of the drug daily.
Clearance is a concept that expresses "the rate of drug removal" in terms of volume
of drug solution removed per unit time (at whatever drug concentration in the body
prevailing at that time). In contrast to a solution in a bottle, the drug concentration
in the body will gradually decline by a first-order process such that the mass of
drug removed over time is not constant. The plasma volume in the healthy state is
relatively constant because water lost through the kidney is rapidly replaced with
fluid absorbed from the gastrointestinal tract.
Example
The relationship of the three drug elimination processes is illustrated in . Note that
in , the fraction Cl/V D is dependent on both the volume of distribution and the rate
of drug clearance from the body. This clearance concept forms the basis of
classical pharmacokinetics and is later extended to flow models in pharmacokinetic
modeling. If the drug concentration is C p, the rate of drug elimination (in terms of
rate of change in concentration, dC p/dt) is: